14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -0.459 1 day ( 0 % )
Last Price $1.16 5.45 %
High/ Low $1.11 - $1.17 16.22%
Chg 7 Days 13.73 % $1.02 $1.16
Chg 30 Days -9.38 % $1.28 $1.16
Chg 12 mos -73.02 % $4.30 $1.16
Trend - 3 mos -19.95 % Width: 42.72 %
Trend - 12 mos -69.49 % Width: 838.15 %
Pred. range - 3 mos $0.782 - $1.12 -32.62 % - -3.84 %
Pred. range - 12 mos N/A - $0.571 -100.00 % - -50.77 %
Short MA avg 3 mos Buy Apr 26, 2024 - 6 days
Long MA avg 3 mos Buy Mar 21, 2024 - 31 days
Short/Long MA avg 3 mos Sell Mar 15, 2024 - 35 days
Short MA avg 12 mos Buy Apr 30, 2024 - 4 days
Long MA avg 12 mos Sell Jan 12, 2024 - 78 days
Short/Long MA avg 12 mos Sell Jan 23, 2024 - 72 days
Pivot Short Sell Apr 25, 2024 - 7 days
Bollinger Buy Apr 12, 2024 - 16 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Allakos Inc.

Allakos. Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical... ALLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT